Literature DB >> 28927551

Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.

Kathryn M Gill1, Sarah A Miller2, Anthony A Grace2.   

Abstract

The methylazoxymethanol acetate (MAM) rodent neurodevelopmental model of schizophrenia exhibits aberrant dopamine system activation attributed to hippocampal dysfunction. Context discrimination is a component of numerous behavioral and cognitive functions and relies on intact hippocampal processing. The present study explored context processing behaviors, along with dopamine system activation, during fear learning in the MAM model. Male offspring of dams treated with MAM (20mg/kg, i.p.) or saline on gestational day 17 were used for electrophysiological and behavioral experiments. Animals were tested on the immediate shock fear conditioning paradigm, with either different pre-conditioning contexts or varying amounts of context pre-exposure (0-10 sessions). Amphetamine-induced locomotor activity and dopamine neural activity was measured 1-week after fear conditioning. Saline, but not MAM animals, demonstrated enhanced fear responses following a single context pre-exposure in the conditioning context. One week following fear learning, saline rats with 2 or 7min of context pre-exposure prior to fear conditioning also demonstrated enhanced amphetamine-induced locomotor response relative to MAM animals. Dopamine neuron recordings showed fear learning-induced reductions in spontaneous dopamine neural activity in MAM rats that was further reduced by amphetamine. Apomorphine administration confirmed that reductions in dopamine neuron activity in MAM animals resulted from over excitation, or depolarization block. These data show a behavioral insensitivity to contextual stimuli in MAM rats that coincide with a less dynamic dopamine response after fear learning.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Context discrimination; Dopamine; Electrophysiology; Fear learning; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28927551      PMCID: PMC5854517          DOI: 10.1016/j.schres.2017.08.064

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  93 in total

1.  Ventral subiculum involvement in latent inhibition context specificity.

Authors:  Esperanza Quintero; Estrella Díaz; Juan Pedro Vargas; Gonzalo de la Casa; Juan Carlos López
Journal:  Physiol Behav       Date:  2010-12-10

2.  The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories.

Authors:  Patricia Matus-Amat; Emily A Higgins; David Sprunger; Karli Wright-Hardesty; Jerry W Rudy
Journal:  Behav Neurosci       Date:  2007-08       Impact factor: 1.912

3.  Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.

Authors:  Ornella Valenti; Pierangelo Cifelli; Kathryn M Gill; Anthony A Grace
Journal:  J Neurosci       Date:  2011-08-24       Impact factor: 6.167

4.  Pilocarpine-induced temporal lobe epilepsy in the rat is associated with increased dopamine neuron activity.

Authors:  Pierangelo Cifelli; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2011-07-12       Impact factor: 5.176

5.  Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer).

Authors:  Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2014-02-20       Impact factor: 9.306

6.  Memory retrieval after contextual fear conditioning induces c-Fos and JunB expression in CA1 hippocampus.

Authors:  T Strekalova; B Zörner; C Zacher; G Sadovska; T Herdegen; P Gass
Journal:  Genes Brain Behav       Date:  2003-02       Impact factor: 3.449

7.  Enhancement of latent inhibition in patients with chronic schizophrenia.

Authors:  Gilad Gal; Yael Barnea; Lior Biran; Shlomo Mendlovic; Tamir Gedi; Michal Halavy; Joram Feldon; Shmuel Fennig; Yechiel Levkovitz
Journal:  Behav Brain Res       Date:  2008-08-28       Impact factor: 3.332

8.  A specific deficit in context processing in the unaffected siblings of patients with schizophrenia.

Authors:  Angus W MacDonald; Michael F Pogue-Geile; Melissa K Johnson; Cameron S Carter
Journal:  Arch Gen Psychiatry       Date:  2003-01

9.  Overgeneral memory for public and autobiographical events in depression and schizophrenia.

Authors:  Zeffa Warren; Catherine Haslam
Journal:  Cogn Neuropsychiatry       Date:  2007-07       Impact factor: 1.871

10.  Learning and generalization in schizophrenia: effects of disease and antipsychotic drug treatment.

Authors:  Daphna Shohamy; Perry Mihalakos; Ronald Chin; Binu Thomas; Anthony D Wagner; Carol Tamminga
Journal:  Biol Psychiatry       Date:  2009-12-24       Impact factor: 13.382

View more
  5 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity.

Authors:  Daniela L Uliana; Leonardo B M Resstel; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-23       Impact factor: 7.853

3.  Neonatal Rotenone Administration Induces Psychiatric Disorder-Like Behavior and Changes in Mitochondrial Biogenesis and Synaptic Proteins in Adulthood.

Authors:  Amanda Siena; Jéssica Mayumi Camargo Yuzawa; Aline Camargo Ramos; Elisandra Henrique; Mariana Dutra Brito; Mariana Bendlin Calvazara; Tatiana Rosado Rosenstock
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

4.  Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.

Authors:  Fernanda F Peres; Mariana C Diana; Raquel Levin; Mayra A Suiama; Valéria Almeida; Ana M Vendramini; Camila M Santos; Antônio W Zuardi; Jaime E C Hallak; José A Crippa; Vanessa C Abílio
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

5.  Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia.

Authors:  Millie Rincón-Cortés; Anthony A Grace
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.